Reliable prediction of outcomes of aneurysmal subarachnoid hemorrhage (aSAH) based on
factors available at patient admission may support responsible allocation of resources as …

Background Patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH) often
receive delayed or no aneurysm treatment, although recent studies suggest that functional …

Background and Purpose—The mortality and morbidity after aneurysmal subarachnoid
hemorrhage has improved because of better diagnosis, early treatment to secure the …

Objective: Patients with poor-grade aneurysm subarachnoid hemorrhage (SAH) have
commonly been considered to have a poor prognosis. The objective of this study was to …

Background: Several clinical studies have indicated the efficacy of cilostazol, a selective
inhibitor of phosphodiesterase 3, in preventing cerebral vasospasm after aneurysmal …

Objective Patients presenting with poor-grade aneurysmal subarachnoid hemorrhage (SAH)
have commonly been reported to have a poor prognosis; however, several reports suggest a …

OBJECT The literature has conflicting reports about the prognostic value of premorbid
hypertension and neurological status in aneurysmal subarachnoid hemorrhage (SAH). The …

OBJECT Current data show a favorable outcome in up to 50% of patients with World
Federation of Neurosurgical Societies (WFNS) Grade V subarachnoid hemorrhage (SAH) …

Background and purpose There are numerous grading scales to describe the severity of
aneurysmal subarachnoid hemorrhage (aSAH) and to predict outcome. Historically …

Background Patients with Hunt-Hess (HH) 5 aneurysmal subarachnoid hemorrhage (SAH)
have high mortality rates. Despite an initial moribund exam, a subset of patients progress to …